Back
Robert Half Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
44
RHI
Robert Half
Last Price:
$69.94
Seasonality Move:
11.27%
Sell
45
DRUG
Bright Minds Biosciences
Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
44
Robert Half (RHI)
is a Sell
Is Robert Half a Buy, Sell or Hold?
-
The current Robert Half [RHI] share price is $69.95. The Score for RHI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RHI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHI Stock Price Chart
What is Robert Half's stock price today?
-
The Robert Half share price today is $69.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHI is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $39.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
RHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.93 | Sell |
Relative Strength Index (14 RSI): | 40.46 | Sell |
Chaikin Money Flow: | 751507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.84 - 75.06) | Sell |
Bollinger Bands (100): | (63.55 - 73.43) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 51.96 | Buy |
Chaikin Money Flow: | 6916 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.23 - 42.31) | Buy |
Bollinger Bands (100): | (3.23 - 44.21) | Buy |
RHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.55 | Sell |
20-day SMA: | 72.61 | Sell |
50-day SMA: | 72.61 | Sell |
200-day SMA: | 68.21 | Buy |
8-day EMA: | 70.52 | Sell |
20-day EMA: | 71.8 | Sell |
50-day EMA: | 71.59 | Sell |
200-day EMA: | 70.23 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.78 | Buy |
20-day SMA: | 38.81 | Buy |
50-day SMA: | 41.79 | Sell |
200-day SMA: | 12.42 | Buy |
8-day EMA: | 39 | Buy |
20-day EMA: | 39.09 | Buy |
50-day EMA: | 36.04 | Buy |
200-day EMA: | 18.43 | Buy |
Robert Half Earnings Growth & RHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $1.16 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Robert Half Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |